:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::
¡¡
¡¡
   
  Herbal Compound Farnesiferol C Exerts Antiangiogenic and Antitumor Activity and Targets Multiple Aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) Signaling Cascades
  ±Û¾´ÀÌ : ÃÖ°í°ü¸®ÀÚ     ³¯Â¥ : 10-02-11 10:43     Á¶È¸ : 1876    
   (1-1)201001.pdf (674.3K), Down : 25, 2010-02-11 10:43:14
Jae-Ho Lee1, Sun Choi2, Yoonji Lee2, Hyo-Jeong Lee1,3, Kwan-Hyun Kim1, Kyoo-Seok Ahn1,Hyunsoo Bae1, Hyo-Jung Lee1, Eun-Ok Lee1, Kwang-Seok Ahn1, Shi Yong Ryu4, Junxuan Lu3, and Sung-Hoon Kim1,3

Mol Cancer Ther; 9(2) February 2010

Corresponding Authors: Sung-Hoon Kim, College of Oriental Medicine, Kyunghee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 131-701, Republic of Korea. E-mail: sungkim7@khu.ac.kr or Junxuan Lü, Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912. Phone: 507-437-9680; Fax: 507-437-9606. E-mail: jlu@hi.umn.edu

   

:::°æÈñ´ëÇб³ ÇÑÀÇ°ú´ëÇÐ ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬¼ö¼¾ÅÍ¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù:::